Antiplatelet, anticoagulant or both? A tool for pharmacists
A Schmode, M Ackman… - … Journal/Revue des …, 2019 - journals.sagepub.com
Patients with atrial fibrillation (AF) are at an increased risk for thrombosis, and anticoagulant
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
Antiplatelet, anticoagulant or both? A tool for pharmacists.
A Schmode, M Ackman, TJ Bungard - … Pharmacists Journal: CPJ …, 2019 - europepmc.org
Patients with atrial fibrillation (AF) are at an increased risk for thrombosis, and anticoagulant
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
[引用][C] Antiplatelet, anticoagulant or both? A tool for pharmacists
A Schmode, M Ackman… - … journal: CPJ= Revue …, 2019 - pubmed.ncbi.nlm.nih.gov
[HTML][HTML] Antiplatelet, anticoagulant or both? A tool for pharmacists
A Schmode, M Ackman, TJ Bungard - … Pharmacists Journal: CPJ, 2019 - ncbi.nlm.nih.gov
Patients with atrial fibrillation (AF) are at an increased risk for thrombosis, and anticoagulant
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
Antiplatelet, anticoagulant or both? A tool for pharmacists.
A Schmode, M Ackman, TJ Bungard - … Pharmacists Journal: CPJ …, 2019 - europepmc.org
Patients with atrial fibrillation (AF) are at an increased risk for thrombosis, and anticoagulant
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …
therapy, preferably with a direct oral anticoagulant (DOAC) for most patients, is indicated for …